SCHEMBL8228775

SCHEMBL8228775

Cc1ccc(S(=O)(=O)Nc2cccnc2)cc1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.91
▸ MEN1 O00255 1/20 0.72
▸ KMT2A Q03164 1/20 0.72
▸ ALDH1A1 P00352 8/20 0.71
▸ HTT P42858 4/20 0.71
▸ SMN1; SMN2 Q16637 4/20 0.71
▸ NAMPT P43490 1/20 0.70
▸ LMNA P02545 4/20 0.66
▸ CA12 O43570 1/20 0.65
▸ CA1 P00915 1/20 0.65
▸ CA2 P00918 1/20 0.65
▸ CA9 Q16790 1/20 0.65
▸ TSHR P16473 3/20 0.63
▸ CYP1A2 P05177 1/20 0.63
▸ CYP3A4 P08684 1/20 0.63
▸ CYP2D6 P10635 1/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ CYP2C19 P33261 1/20 0.63
▸ TP53 P04637 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1094118 0.85 MEN1 (0.73) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL31661903 0.85 MEN1 (0.73) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL9568492 0.84 KMT2A (0.72) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL9209937 0.84 KMT2A (0.72) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL5015931 0.84 KEAP1 (0.68) POLBMEN1KMT2AALDH1A1NAMPT
SCHEMBL10031630 0.84 KMT2A (0.72) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL28644956 0.84 KMT2A (1.00) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL11537816 0.82 CA12 (0.68) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL2801932 0.81 KMT2A (0.68) POLBMEN1KMT2AALDH1A1HTT
SCHEMBL22650880 0.81 NAMPT (0.79) POLBMEN1KMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9669399-B2 Phosphine ligands for catalytic reactions ABBVIE INC. (US) 2017-06-06 — — US disclosed
US-20160263566-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBVIE INC. 2016-09-15 — — US disclosed
US-9381508-B2 Phosphine ligands for catalytic reactions ABBVIE INC. (US) 2016-07-05 — — US disclosed
US-20150360215-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBVIE INC. 2015-12-17 — — US disclosed
US-9200021-B2 Phosphine ligands for catalytic reactions ABBVIE INC. (US) 2015-12-01 — — US disclosed
CN-104557859-A Preparation method of balofloxacin UNIV HENAN NORMAL 2015-04-29 — — CN disclosed
WO-2007118137-A1 BENZAMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2007-10-18 — — WO disclosed
EP-0548616-A1 Aqueous chemiluminescent systems AMERICAN CYANAMID COMPANY (US) 1993-06-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160263566-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS PHOSPHO1, PLCG2, PPIP5K2 POLB 494/4885MEN1 1326/4885KMT2A 2485/4885
US-20150360215-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS PHOSPHO1, PLCG2, PPIP5K2 POLB 494/4885MEN1 1326/4885KMT2A 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback